Cicloprolol

Cicloprolol
Clinical data
Other names	Cycloprolol; SL-75177
Identifiers
	IUPAC name 1-[4-[2-(cyclopropylmethoxy)ethoxy]phenoxy]-3-(propan-2-ylamino)propan-2-ol;
CAS Number	63659-12-1 ;
PubChem CID	146294;
IUPHAR/BPS	552;
ChemSpider	129044;
UNII	1K2ACH4U3R;
KEGG	D03490;
ChEBI	CHEBI:135377;
ChEMBL	ChEMBL2110772;
CompTox Dashboard (EPA)	DTXSID70867026 ;
Chemical and physical data
Formula	C18H29NO4
Molar mass	323.433 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(C)NCC(COC1=CC=C(C=C1)OCCOCC2CC2)O;
	InChI InChI=1S/C18H29NO4/c1-14(2)19-11-16(20)13-23-18-7-5-17(6-8-18)22-10-9-21-12-15-3-4-15/h5-8,14-16,19-20H,3-4,9-13H2,1-2H3; Key:JNDJPKHYZWRRIS-UHFFFAOYSA-N;

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Cicloprolol (INNTooltip International Nonproprietary Name; developmental code name SL-75177), or cycloprolol (BANTooltip British Approved Name), is a β-adrenergic receptor antagonist (beta blocker) described as an antihypertensive agent which was never marketed.^[1]^[2]^[3]^[4]^[5] It has weak partial agonist or intrinsic sympathomimetic activity (30%) at the β-adrenergic receptors.^[4]^[2] This is higher than that of many other beta blockers but is lower than that of xamoterol (45%).^[4] The drug is selective for the β₁-adrenergic receptor.^[3] It has been studied in the treatment of heart failure.^[3]

Chemistry

The chemical structure of cicloprolol is very similar to that of betaxolol.

Synthesis

Cicloprolol can be synthesized starting from 4-benzyloxyphenol.^[6]^[7]

References

^ Elks J (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 272. ISBN 978-1-4757-2085-3. Retrieved 29 August 2024.
^ ^a ^b Morton IK, Hall JM (2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Netherlands. p. 88. ISBN 978-94-011-4439-1. Retrieved 2024-08-29.
^ ^a ^b ^c Persson H, Erhardt L (June 1991). "Beta receptor antagonists in the treatment of heart failure". Cardiovascular Drugs and Therapy. 5 (3): 589–604. doi:10.1007/BF03029728. PMID 1678962.
^ ^a ^b ^c Waller DG (August 1990). "Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?". British Journal of Clinical Pharmacology. 30 (2): 157–171. doi:10.1111/j.1365-2125.1990.tb03760.x. PMC 1368213. PMID 1976342.
^ Cocco G, Alfiero R, Pouleur H (January 1992). "An evaluation of the safety of the beta-modulator cicloprolol in chronic heart failure". Clinical Cardiology. 15 (1): 38–42. doi:10.1002/clc.4960150109. PMID 1347258.
^ DE 2649605, Manoury PM, Cavero IA, Majer H, Giudicelli DP, "Phenoläther, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimttel [Phenol ethers, processes for their preparation and medicinal products containing them]", published 1977-05-18, assigned to Synthelabo S.A.
^ P. M. J. Manouri, I. A. G. Carero, H. Majer, and P. R. L. Giudicelli, (1977) Chem. Abstr., 87:134,543j (1977). eidem U.S. patent 4,311,708

[Elks2014-1] Elks J (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 272. ISBN 978-1-4757-2085-3. Retrieved 29 August 2024.

[MortonHall2012-2] Morton IK, Hall JM (2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Netherlands. p. 88. ISBN 978-94-011-4439-1. Retrieved 2024-08-29.

[PerssonErhardt1991-3] Persson H, Erhardt L (June 1991). "Beta receptor antagonists in the treatment of heart failure". Cardiovascular Drugs and Therapy. 5 (3): 589–604. doi:10.1007/BF03029728. PMID 1678962.

[Waller1990-4] Waller DG (August 1990). "Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?". British Journal of Clinical Pharmacology. 30 (2): 157–171. doi:10.1111/j.1365-2125.1990.tb03760.x. PMC 1368213. PMID 1976342.

[CoccoAlfieroPouleur1992-5] Cocco G, Alfiero R, Pouleur H (January 1992). "An evaluation of the safety of the beta-modulator cicloprolol in chronic heart failure". Clinical Cardiology. 15 (1): 38–42. doi:10.1002/clc.4960150109. PMID 1347258.

[6] DE 2649605, Manoury PM, Cavero IA, Majer H, Giudicelli DP, "Phenoläther, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimttel [Phenol ethers, processes for their preparation and medicinal products containing them]", published 1977-05-18, assigned to Synthelabo S.A.

[7] P. M. J. Manouri, I. A. G. Carero, H. Majer, and P. R. L. Giudicelli, (1977) Chem. Abstr., 87:134,543j (1977). eidem U.S. patent 4,311,708

[1]

[2]

[3]

[4]

[5]

[6]

[7]